Skip to main content Skip to main navigation menu Skip to site footer

No. 1 (2023): INFUSION & CHEMOTHERAPY

ISSN 2663-0338; eISSN 2709-0957
DOI 10.32902/2663-0338

DOI: https://doi.org/10.32902/2663-0338-2023-1

Published: 2023-03-29

Full Issue

FULL ISSUE PDF (Українська)

ORIGINAL STUDIES

Somatopsychic disorders in patients with community-acquired pneumonia associated with coronavirus disease (COVID-19)

Т.О. Pertseva, L.I. Konopkina, Yu.V. Huba, О.О. Shchudro, N.О. Demian

5-13

DOI: https://doi.org/10.32902/2663-0338-2023-1-5-13
- ARTICLE PDF (Українська)
Variants of the post-COVID syndrome course depending on age, gender, comorbidity and severity of COVID-19

L.D. Todoriko, O.S. Shevchenko

14-19

DOI: https://doi.org/10.32902/2663-0338-2023-1-14-19
- ARTICLE PDF (Українська)
The role of comorbidity in the development of Long-COVID

T.V. Chernii, V.I. Chernii, D.A. Fokina

20-24

DOI: https://doi.org/10.32902/2663-0338-2023-1-20-24
- ARTICLE PDF (Українська)
Surgical tactics for the treatment of subpleural and intra-pulmonary hematomas as a result of pneumonia caused by COVID-19

M.S. Opanasenko, S.M. Bilokon, B.M. Konik, O.V. Tereshkovych, S.M. Shalagay, L.I. Levanda, M.I. Kalenychenko, V.B. Bychkovskyi, A.M. Stepaniuk, V.I. Lysenko, M.Yu. Shamray

25-31

DOI: https://doi.org/10.32902/2663-0338-2023-1-25-31
- ARTICLE PDF (Українська)

REVIEW ARTICLE

Edaravone in the treatment of concussion and post-concussion syndrome

O.A. Halushko

32-37

DOI: https://doi.org/10.32902/2663-0338-2023-1-32-37
- ARTICLE PDF (Українська)